CLINICAL_TRIALS
trial_result
· 2022-03-14
Clinical Trial Update: Mass Drug Administration of Ivermectin and Dihydroartemisinin-piperaquine as an Additional Intervention for Malaria Elimination [Phase 3]
Summary
Phase 3 trial evaluating mass drug administration of ivermectin and dihydroartemisinin-piperaquine as an additional intervention for malaria elimination has com…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Malaria | Phase 3 | Status: COMPLETED